跳至主要内容
临床试验/NCT00763061
NCT00763061已完成4 期

A Twelve-Week, Double Masked, Parallel Group, Study of Travoprost 0.004% Compared to Timolol 0.5% in Patients With Open-Angle Glaucoma or Ocular Hypertension

Alcon Research1 个研究点 分布在 1 个国家目标入组 111 人开始时间: 2006年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
111
试验地点
1
主要终点
Mean Intraocular Pressure (IOP) at 9 AM

研究概览

简要总结

To evaluate the Intraocular Pressure (IOP) lowering efficacy and safety of Travoprost 0.004% compared to Timolol 0.5% in patients with open-angle glaucoma (OAG) or ocular hypertension (OH). The study structure is a parallel design. The patients will receive treatment for 12 weeks.

详细描述

To evaluate the IOP lowering efficacy and safety fo Travoprost 0.004% compared to Timolol 0.5% in patients with open-angle glaucoma (OAG) or ocular hypertension (OH). The study structure is a parallel design. The patients will receive treatment for 12 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years;
  • IOP=16-30mmHg
  • OH or OAG with visual filed abnormality:
  • ≥3 adjacent points in 24 degrees field on the same side of the horizontal meridian, that have p <5% on the prepapillary diameter plot, one of which must have p <1%,
  • Glaucoma Hemifield Test outside normal limits,
  • Corrected Pattern Standard Deviation with p <5%

排除标准

  • Previous damage of anterior chamber angle;
  • ocular inflammation or ocular surgery within the past 3 months; Best Corrected Visual Acuity (logMAR) <1.0;
  • contact lens wearer;
  • severe central field loss;
  • uncontrolled cardiovascular, hepatic or renal disease;
  • any medication within past 1 month.

研究组 & 干预措施

Travoprost 0.004%

Experimental

Travoprost 0.004%

干预措施: Travoprost 0.004% Ophthalmic Solution (Travatan) (Drug)

Timolol 0.5%

Active Comparator

Timolol 0.5%

干预措施: Timolol 0.5% Ophthalmic Solution (Timoptic) (Drug)

结局指标

主要结局

Mean Intraocular Pressure (IOP) at 9 AM

时间窗: At Week 12 - At the 9 AM time point for the patient's worse eye.

Bilateral IOP measurements by Goldmann applanation were performed at 9AM and 4 PM. Two IOP measurements were taken and averaged. If the difference between the first and second reading was greater than 4 mmHg, a third reading was taken and the two nearest readings averaged.

Week 12 - Mean IOP At 4 PM

时间窗: At the 4 PM time point for the patient's worse eye.

Bilateral IOP measurements by Goldmann applanation were performed at 9AM and 4 PM. Two IOP measurements were taken and averaged. If the difference between the first and second reading was greater than 4 mmHg, a third reading was taken and the two nearest readings averaged.

次要结局

  • Mean IOP Change From Baseline at 9 AM(Baseline to Week 12 - at 9 AM)
  • Mean IOP Change at 4 PM(Baseline to Week 12 - at 4 PM)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Travatan Versus Timoptic in Treating Open-angle... | 临床试验